Perioperative pentoxifylline therapy attenuates early postoperative neuro-cognitive decline in patients undergoing coronary artery bypass grafting surgery using cardiopulmonary bypass

Abstract

Background: Postoperative cognitive decline (POCD) after coronary artery bypass grafting (CABG) is a common problem. Studies show that pentoxifylline administration reduces inflammation induced by cardiopulmonary bypass and brain injury after ischaemia. Hence the perioperative use of pentoxifylline in attenuating POCD was evaluated in the study. Materials and Methods: Eighty patients were divided randomly into two groups from 106 patients scheduled for CABG surgery. The study group was administered pentoxifylline 400 mg twice daily orally from day of admission to 7th day after surgery, whereas the control group patients received placebo. Neurocognitive assessment was assessed by an independent clinical psychologist one day after admission to hospital and again on 7th postoperative day. The data was analyzed and a P < 0.05 was considered significant results. Results: Pentoxifylline-treated group showed no statistically significant difference in animal naming test scores (10.3 ± 2.2 versus 9.4 ± 2.5, P = 0.07), digit symbol substitution test (26.1 ± 7.47 vs 22.2 ± 6.07, P = 0.09) and 8 subtests of Post Graduate Institute-memory scale. The control group had significant POCD as detected by animal naming test (10.5 ± 3.7 versus 8.6 ± 3.9, P = 0.008), digit symbol substitution test (20.2 ± 8.2 versus 14.7 ± 8.9, P = 0.008) and five subtests of memory scale (P = 0.01, 0.04, 0.003, 0.005 and 0.02). The incidence of POCD was 50% in placebo-treated group compared to 22.5% in pentoxifylline group. Conclusions: The perioperative use of pentoxifylline attenuates the early postoperative neurocognitive decline after CABG using cardiopulmonary bypass.

Keywords

Cardiopulmonary bypass - coronary artery bypass grafting - neurocognitive assessment tests - pentoxifylline - postoperative neurocognitive decline

• REFERENCES

• 1 Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R. et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996; 335: 1857-63
• 2 Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG. et al. Neurologic Outcome Research Group and the Cardiothoracic Anesthesia Research Endeavors (CARE) Investigators of the Duke Heart Center. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke 2001; 32: 2874-81
• 3 Zamvar V, Williams D, Hall J, Payne N, Cann C, Young K. et al. Assessment of neurocognitive impairment after off- pump and on-pump techniques for coronary artery bypass graft surgery: Prospective randomised controlled trial. BMJ 2002; 325: 1268
• 4 Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH. et al. Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344: 395-402
• 5 Orhan G, Sargin M, Senay S, Yuksel M, Kurc E, Tasdemir M. et al. Systemic and myocardial inflammation in traditional and off-pump cardiac surgery. Tex Heart Inst J 2007; 34: 160-5
• 6 Cagli K, Ulas MM, Ozisik K, Kale A, Bakuy V, Emir M. et al. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 2005; 20: 45-51
• 7 Drug information on pentoxifylline (Trental) version 2007. Sanofi-Aventis Pharmaceutical; USA: Available from: http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=65977 [Last accessed on 2010 Apr].
• 8 Banfi C, Sironi L, De Simoni G, Gelosa P, Barcella S, Perego C. et al. Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats. J Pharmacol Exp Ther 2004; 310: 890-5
• 9 Eun BL, Liu XH, Barks JD. Pentoxifylline attenuates hypoxic-ischemic brain injury in immature Rats. Pediatr Res 2000; 47: 73-8
• 10 Pershad D, Verma SK. Handbook of PGI battery of brain dysfunction (PGI-BBD). Agra, India: National Psychological Corporation; 1990
• 11 Lezak MD. Neuropsychological assessment. Oxford: Oxford University Press; 1995
• 12 Rosen. Rosen WG. Verbal fluency in aging and dementia. J Clin Neuropsychol 1980; 2: 135-46
• 13 Heringlake M, Heinrichs G, Weber CF, Rosemann C, Bahlmann L, Eichler W. et al. The anti-inflammatory and organ-protective effects of pentoxifylline during cardiac surgery. Appl Cardiopulm Pathophysiol 2007; 11: 17-23
• 14 Heinze H, Rosemann C, Weber C, Heinrichs G, Bahlmann L, Misfeld M. et al. A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery - A prospective randomized and controlled study. Eur J Cardiothorac Surg 2007; 32: 83-9
• 15 Gao L, Taha R, Gauvin D, Othmen LB, Wang Y, Blaise G. Postoperative cognitive dysfunction after cardiac surgery. Chest 2005; 128: 3664-70
• 16 Royter V, Bornstein MN, Russell D. Coronary artery bypass grafting (CABG) and cognitive decline: A review. J Neurol Sci 2005; 229–230: 65-7